Futuximab

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Futuximab
Accession Number
DB15262
Type
Biotech
Groups
Investigational
Description

Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).

Synonyms
Not Available
External IDs
SYM004
Categories
Not Available
UNII
B37J680LX0
CAS number
1310460-85-5

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Futuximab

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentTumors, Solid1
1TerminatedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1, 2CompletedTreatmentMetastatic Colorectal Cancer (MCRC)1
1, 2TerminatedTreatmentMetastatic Colorectal Cancer (MCRC)1
1, 2WithdrawnTreatmentSquamous Non-Small Cell Lung Cancer1
2Active Not RecruitingTreatmentGliomas, Malignant1
2CompletedTreatmentCarcinoma, Squamous Cell of Head and Neck1
2CompletedTreatmentMetastatic Colorectal Cancer (MCRC)1
2TerminatedTreatmentCarcinoma NOS / Metastatic Colorectal Cancer (MCRC)1
2WithdrawnTreatmentMetastatic Colorectal Cancer (MCRC)1
3WithdrawnTreatmentCarcinoma NOS / Metastatic Colorectal Cancer (MCRC)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:05 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates